784181-14-2Relevant academic research and scientific papers
SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS
-
Page/Page column 0358-0360, (2020/12/14)
The present invention relates to the use of a compound of the general formula (I) in which M and D have the meanings given in the description for controlling animal pests.
5-Membered heterocyclic compound
-
Page/Page column 69, (2009/07/03)
The present invention provides 5-membered heterocycle compounds represented by the following general formula (I): The present compounds have a superior acid secretion inhibitory effect, and shows an antiulcer activity and the like.
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists
Carpino, Philip A.,Griffith, David A.,Sakya, Subas,Dow, Robert L.,Black, Shawn C.,Hadcock, John R.,Iredale, Philip A.,Scott, Dennis O.,Fichtner, Michael W.,Rose, Colin R.,Day, Robert,Dibrino, Joseph,Butler, Mary,DeBartolo, Demetria B.,Dutcher, Darrin,Gautreau, Denise,Lizano, Jeff S.,O'Connor, Rebecca E.,Sands, Michelle A.,Kelly-Sullivan, Dawn,Ward, Karen M.
, p. 731 - 736 (2007/10/03)
A series of conformationally constrained bicyclic derivatives derived from SR141716 was prepared and evaluated as hCB1-R antagonists and inverse agonists. Optimization of the structure-activity relationships around the 2,6-dihydro-pyrazolo[4,3-
BICYCLIC PYRIDAZINONE CANNABINOID RECEPTOR LIGANDS AND USES THEREOF
-
Page/Page column 46, (2010/02/12)
Compounds of Formula (I) and (II) are described herein, as well as their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors (in particular, the CB-1 receptor) in animals.
Cannabinoid receptor ligands and uses thereof
-
Page 25-26, (2010/02/09)
Compounds of Formula (I) or (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
Cannabinoid receptor ligands and uses thereof
-
Page 20, (2008/06/13)
Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
